Updated Results for Investigational Therapy Tepotinib Presente...
DARMSTADT, Germany, Sept. 9, 2019 /PRNewswire-AsiaNet/-- - Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study - Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epid...
Authors: LATEST ASIANET NEWS RELEASES